ARA-290 20 mg

Strength 20 mg / 3 mLPurity HPLCForm Pre-filled penCOA Per batch

A non-erythropoietic peptide derived from erythropoietin (also known as Cibinetide), studied for activating the innate repair receptor and for tissue-protective and anti-inflammatory endpoints.

Researched directions

Innate repair receptor signalling research
Neuropathic-pain and small-fibre models
Anti-inflammatory and tissue-protection endpoints
Metabolic and wound-research studies

Request access to order Ask the lab

Available to verified researchers. Pricing and the batch Certificate of Analysis are shared on request.

About ARA-290

ARA-290 is a short peptide derived from the EPO molecule that retains its tissue-protective activity without stimulating red-blood-cell production. It is studied for reducing inflammation and protecting nerve tissue in neuropathy and repair research.

Features

ARA-290 is supplied in the NADOVA LABS GoQuick pre-filled pen — a graduated, ready-to-use subcutaneous delivery format that removes reconstitution and simplifies repeat-dose study designs. Each pen is prepared from HPLC-verified material, dose-marked on the barrel, and shipped refrigerated with a Certificate of Analysis available per batch.

Handling & compliance

This pre-filled pen is intended strictly for in-vitro and laboratory research. It is not a drug, supplement, or medical device, and is not for human or veterinary use. Store refrigerated at 2–8 °C, protect from light, and follow accepted laboratory practice; exact specifications for your lot are listed on its Certificate of Analysis.

Back to catalogue

Pen

Repair · Recovery blend

Tri-Heal 20 mg

A TB-500 + BPC-157 recovery blend studied for tissue repair and angiogenesis research.

View 20 mg

Pen

Repair · Recovery

TB-500 15 mg

A thymosin β4 fragment studied for recovery, angiogenesis and tissue-repair models.

View 15 mg

Pen

Repair · Recovery blend

Klow 40 mg

A four-peptide repair blend (TB-500, BPC-157, KPV, GHK-Cu) for recovery research.

View 40 mg